AstraLabel SOLO — CFO & Finance Leadership

Predictable subscription cost. No implementation surprise. No investor margin in your fees.

AstraLabel SOLO is CHF 15,000 per month. Fixed. Your fees fund the platform infrastructure — not a vendor's growth targets. PharmaLedger Association is a Swiss nonprofit.

CHF 15,000 / month fixedSwiss nonprofitNo data monetisationNo hidden implementation costs

Request a conversation

We respond within one business day.

COMMERCIAL MODEL

Fixed monthly subscriptionNo per-market pricingNo volume overages on repositoriesNonprofit structure — fees fund the work, not investor returns

The total cost question

Three cost categories that ePI programme budgets routinely underestimate.

01The build cost is only the start of an in-house ePI programme. Engineering capacity to build the content management layer. GxP validation of a custom system. Integration projects with each national health authority repository — separately, with different formats and update cycles. Legal review of data handling per jurisdiction. Ongoing maintenance as national requirements change. This is not a project. It is a standing infrastructure cost.
02Proprietary vendor pricing structures grow with your portfolio. Per-leaflet fees, per-market fees, per-submission fees. An ePI programme that covers 50 markets and 200 active leaflets on a per-unit pricing model carries significant exposure to cost escalation as the portfolio grows — and vendors with shareholder pressure have incentives to ratchet those fees upward at renewal.
03The compliance risk of a delayed or failed ePI programme has a financial dimension. EU ePI transition deadlines are regulatory requirements. A programme that is not production-ready by the applicable deadline carries regulatory exposure — and the cost of emergency remediation is invariably higher than the cost of a well-planned implementation.

The AstraLabel commercial model

Transparent pricing. No hidden cost vectors.

AstraLabel SOLO — fixed subscription

CHF 15,000 per month (CHF 180,000 per year). Includes dedicated infrastructure, API access, implementation, and distribution to all 46+ market repositories. No per-market fee. No per-leaflet fee for distribution. No volume overage on repository submissions.

Nonprofit structure — no growth tax

PharmaLedger Association is a Swiss nonprofit. Fees fund the platform infrastructure and operating costs — not investor returns or vendor growth targets. There is no mechanism by which shareholder pressure translates into pricing pressure at renewal. The fee structure is stable because the incentive structure is stable.

What is included in CHF 15,000 / month

✓ Dedicated infrastructure environment

✓ API access (standard rate limits)

✓ Distribution to 46+ market repositories

✓ 29-language structured content support

✓ GxP-validated platform

✓ SDLC-ready validation documentation

✓ Implementation (1–2 months)

✓ Ongoing format compliance maintenance

XML conversion available as an optional add-on. PLA Members receive 10–20% discount.

Build vs buy — the financial case

The cost comparison that internal ePI project sponsors often do not bring to the finance team.

In-house ePI programme — true cost components

Engineering capacity (full-time staff or agency). GxP validation of custom system. Integration development per national repository. Legal and compliance review per jurisdiction. Ongoing maintenance as national formats evolve. Internal project management overhead. Cost of delay if deadline is missed.
Typically: 18–36 months to full multi-market capability. Ongoing maintenance team required permanently.

AstraLabel SOLO — full cost

CHF 180,000 per year. Implementation in 1–2 months. No internal engineering team required. No per-market integration projects. No ongoing maintenance overhead. GxP validation documentation included. 46 markets from day one.
Live in 1–2 months. No standing internal team required.

The membership efficiency

For larger AstraLabel contracts, PLA Membership can reduce the effective cost.

Standard PLA Membership includes a 10% discount on AstraLabel SOLO pricing. Patron Membership includes a 20% discount plus a Board seat. For organisations where the membership fee is less than the AstraLabel discount saving, Membership is financially net-positive.

10%Standard Membership discount
CHF 18,000 saving on SOLO

20%Patron Membership discount
CHF 36,000 saving on SOLO

Also for your role

Animal Health Human Health Artwork & Packaging Supply Chain CFO & Finance Legal & Compliance Regulatory Affairs

Common questions

Frequently asked questions

Is the CHF 15,000/month price locked, or does it increase at renewal?

AstraLabel SOLO is priced on a fixed annual subscription model. PLA does not apply automatic annual price increases. Any pricing change at renewal is subject to negotiation and requires written agreement. The nonprofit structure removes the commercial incentive to ratchet fees upward — fee increases would need to be justified by genuine infrastructure cost increases.

What is the contract term and exit clause?

Standard contract term is 12 months with annual renewal. Exit provisions are negotiated at contract stage. There is no lock-in beyond the contracted term. We can provide standard contract terms in advance of the procurement conversation.

We are in a vendor consolidation initiative — can AstraLabel cover the full ePI scope across all our markets?

AstraLabel SOLO covers 46 countries and 29 languages. For a Top-50 MAH, this covers the vast majority of commercially significant markets. A small number of markets with bespoke regulatory frameworks may require market-specific implementation — we scope this in the pre-sales conversation and provide a clear statement of coverage.

Is PLA financially stable? What is the governance model for a nonprofit vendor?

PLA is a Swiss nonprofit (CHE-178.875.143 MWST) governed by a Board of Directors that includes representatives from GSK, MSD, and Takeda. Financial statements are audited by an independent auditor. The organisation is structured to be platform-revenue funded — not grant-dependent. We provide governance and financial overview documentation to finance teams on request.

Can we audit the platform or conduct a vendor risk assessment?

Yes. PLA supports vendor risk assessments as part of the standard procurement process. We provide: GxP validation documentation, SOC 2 Type II scope documentation (H2 2026), data processing agreement, security overview, and financial governance summary. Contact us to initiate the assessment process.

A predictable subscription. A nonprofit structure. A 30-minute commercial conversation.

We send the full commercial terms, pricing model, and governance documentation before the call — so the conversation starts from facts, not a sales pitch.

Request a commercial terms overview